397 related articles for article (PubMed ID: 29057814)
1. A New Noncanonical Anionic Peptide That Translocates a Cellular Blood-Brain Barrier Model.
Neves-Coelho S; Eleutério RP; Enguita FJ; Neves V; Castanho MARB
Molecules; 2017 Oct; 22(10):. PubMed ID: 29057814
[TBL] [Abstract][Full Text] [Related]
2. From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery.
Soddu E; Rassu G; Giunchedi P; Sarmento B; Gavini E
Eur J Pharm Sci; 2015 Jul; 74():63-76. PubMed ID: 25892455
[TBL] [Abstract][Full Text] [Related]
3. Strategies for transporting nanoparticles across the blood-brain barrier.
Zhang TT; Li W; Meng G; Wang P; Liao W
Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
[TBL] [Abstract][Full Text] [Related]
4. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
Zhou X; Smith QR; Liu X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1695. PubMed ID: 33470550
[TBL] [Abstract][Full Text] [Related]
5. Harnessing the capacity of cell-penetrating peptides for drug delivery to the central nervous system.
Kang T; Gao X; Chen J
Curr Pharm Biotechnol; 2014; 15(3):220-30. PubMed ID: 24938893
[TBL] [Abstract][Full Text] [Related]
6. Peptides for trans-blood-brain barrier delivery.
Blades R; Ittner LM; Tietz O
J Labelled Comp Radiopharm; 2023 Jul; 66(9):237-248. PubMed ID: 37002811
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system delivery of molecules across the blood-brain barrier.
Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
[TBL] [Abstract][Full Text] [Related]
8. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
[TBL] [Abstract][Full Text] [Related]
9. The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain.
Sharma G; Lakkadwala S; Modgil A; Singh J
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231900
[TBL] [Abstract][Full Text] [Related]
10. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
11. Combination of Cell-Penetrating Peptides with Nanoparticles for Therapeutic Application: A Review.
Silva S; Almeida AJ; Vale N
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30634689
[TBL] [Abstract][Full Text] [Related]
12. Cell-Penetrating Peptides: As a Promising Theranostics Strategy to Circumvent the Blood-Brain Barrier for CNS Diseases.
Varnamkhasti BS; Jafari S; Taghavi F; Alaei L; Izadi Z; Lotfabadi A; Dehghanian M; Jaymand M; Derakhshankhah H; Saboury AA
Curr Drug Deliv; 2020; 17(5):375-386. PubMed ID: 32294035
[TBL] [Abstract][Full Text] [Related]
13. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.
Xie J; Shen Z; Anraku Y; Kataoka K; Chen X
Biomaterials; 2019 Dec; 224():119491. PubMed ID: 31546096
[TBL] [Abstract][Full Text] [Related]
14. Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers.
Mulvihill JJ; Cunnane EM; Ross AM; Duskey JT; Tosi G; Grabrucker AM
Nanomedicine (Lond); 2020 Jan; 15(2):205-214. PubMed ID: 31916480
[TBL] [Abstract][Full Text] [Related]
15. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
[TBL] [Abstract][Full Text] [Related]
16. Food-Derived Peptides: Beneficial CNS Effects and Cross-BBB Transmission Strategies.
Li Z; Dang Q; Wang P; Zhao F; Huang J; Wang C; Liu X; Min W
J Agric Food Chem; 2023 Dec; 71(51):20453-20478. PubMed ID: 38085598
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases.
Ceña V; Játiva P
Nanomedicine (Lond); 2018 Jul; 13(13):1513-1516. PubMed ID: 29998779
[No Abstract] [Full Text] [Related]
18. The improved blood-brain barrier permeability of endomorphin-1 using the cell-penetrating peptide synB3 with three different linkages.
Liu H; Zhang W; Ma L; Fan L; Gao F; Ni J; Wang R
Int J Pharm; 2014 Dec; 476(1-2):1-8. PubMed ID: 25245547
[TBL] [Abstract][Full Text] [Related]
19. Recombinant single-chain antibody with the Trojan peptide penetratin positioned in the linker region enables cargo transfer across the blood-brain barrier.
Skrlj N; Drevenšek G; Hudoklin S; Romih R; Curin Šerbec V; Dolinar M
Appl Biochem Biotechnol; 2013 Jan; 169(1):159-69. PubMed ID: 23160949
[TBL] [Abstract][Full Text] [Related]
20. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
Goyal K; Koul V; Singh Y; Anand A
Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
